This is further supported by conflicting reports in cancer, as increased IL-32 levels associate with enhanced anti-tumor immunity and good patient prognosis in cutaneous melanoma (5) but tumor progression in many epithelial cancers (6, 7). Here, IL32 is linked to cancer.